Dow Down 0.43% Nasdaq Down 0.04%

Ligand Pharmaceuticals Incorporated (LGND)

-NGM
52.97 Up 0.92(1.78%) 1:00PM EDT - Nasdaq Real Time Price
Prev Close:52.04
Open:52.71
Bid:53.04 x 200
Ask:53.13 x 100
1y Target Est:84.80
Beta:1.23
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:52.56 - 53.56
52wk Range:39.75 - 80.42
Volume:186,654
Avg Vol (3m):392,280
Market Cap:1.10B
P/E (ttm):90.85
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDUp 1.78%1.10B
LLYDown 0.02%68.11B
MRKDown 0.60%172.36B
RHHBYDown 0.16%247.67B

Key Statistics

Forward P/E (1 yr):21.86
P/S (ttm):19.91
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback